ACCESS Newswire

ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium

Share

TORONTO, ON / ACCESSWIRE / December 6, 2024 / ProteinQure, the leading company in computational design of peptide therapeutics, will be presenting compelling new data on the progress of their lead triple negative breast cancer (TNBC) drug PQ203 (December 12, 2024 presentation ID: P4-12-17) at the 2024 San Antonio Breast Cancer Symposium.

PQ203 is a novel Peptide Drug Conjugate composed of a Sortilin receptor targeting peptide conjugated to the cytotoxic agent monomethyl auristatin E. The Sortiin receptor is expressed in a high percentage of diseased tissue from TNBC patients and as such represents an innovative treatment for this challenging sub-type of breast cancer.

ProteinQure has recently generated data that PQ203 exhibits potent efficacy in a patient-derived xenograft (PDX) model resistant to Sacituzumab Govitecan (Trodelvy™), an antibody drug conjugate that is the emerging standard of care for metastatic TNBC. Additionally, PQ203 has shown an encouraging safety profile. Based on these findings as well as earlier in vivo efficacy studies, ProteinQure has initiated GLP-toxicology studies for PQ203 in support of an anticipated investigational new drug application filing in Q2 of 2025.

"These combined findings confirm the power of our computational drug design platform and its potential to address key challenges in cancer therapy. We are deeply committed to moving PQ203 forward and are eager to bring this innovative treatment to clinical trials." stated Lucas Siow, CEO of ProteinQure.

Phase 1a/b trial initiation for PQ203 is planned for the second half of 2025 and will be coordinated at the Princess Margaret Cancer Center in Toronto and other leading hospitals in North America.

For media inquiries please contact Lucas Siow at lucas@proteinqure.com

SOUCE: ProteinQure Inc.



View the original press release on accesswire.com

ProteinQure Inc.

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

An Incredible KLAS Triple-Award Win for AGFA HealthCare!10.2.2025 09:00:00 CET | Press release

MORTSEL, BE / ACCESS Newswire / February 10, 2025 / AGFA HealthCare proudly celebrates a remarkable KLAS triple-win, securing two #1 Best in KLAS Awards for XERO® Viewer and VNA, alongside the KLAS Most Improved Software Product for 2025. "To receive a KLAS Award is one of the most notable wins for AGFA HealthCare, and a testament to the hard work we invest into our flagship platform. More importantly, it reflects the trust and recognition from our customers. Their success is our success, and to receive two such awards is simply breathtaking." - Nathalie McCaughley, President, AGFA HealthCare The Best in KLAS report recognizes software and service providers who excel in supporting healthcare professionals and patient care. Based on extensive customer feedback and evaluations, these awards highlight AGFA HealthCare's unwavering commitment to innovation and excellence. For 2025, AGFA HealthCare's Enterprise Imaging XERO® Viewer leads the Universal Viewer (Imaging) category for the second

Eviva Partners, a New Nonprofit Promoting Better Understanding of Medical Evidence, Exposes Role of Andrew Wakefield in the “Manufacture of Evidence” Leading Up to Robert F. Kennedy Jr’s Confirmation Hearings10.2.2025 07:50:00 CET | Press release

Introduces the concept of "Evidence Fluency" as a solution to the current crisis and a path towards improving healthcare overall NEW YORK CITY, NEW YORK / ACCESS Newswire / February 10, 2025 / Eviva Partners, a pioneering healthcare initiative founded by physician-scientist Alex Morozov, announced its launch today with an innovative mission to address critical gaps in healthcare delivery through "evidence fluency" - a new framework for understanding and communicating medical evidence. "The new US Administration is poised to have a dramatic impact on the integrity of scientific publications and medical evidence," said Alex Morozov, CEO and Founder. "An investigation over the past several days reveals a role of Andrew Wakefield in the "Manufacture of Evidence" leading up to Robert F. Kennedy Jr's Confirmation hearings. Wakefield 30 years ago was paid by another anti-vaccine lawyer, Richard Barr, to manufacture a study through research fraud showing a link between vaccines and autism. His

Registration Now Open for World of Coffee 2025 in Geneva: The Premier Event for Coffee Professionals6.2.2025 09:00:00 CET | Press release

Join Over 13,000 Attendees and 430+ Exhibitors at Europe's Largest Specialty Coffee Trade Show GENEVA, SWITZERLAND / ACCESS Newswire / February 6, 2025 / World of Coffee, the essential event for coffee professionals, enthusiasts, and innovators from around the globe will have a 2025 edition in Geneva, Switzerland, at the Palexpo SA, June 26-28. Following the record-breaking success of World of Coffee in Copenhagen, this flagship coffee trade show is set to welcome over 13,000 coffee professionals from 160+ countries for three days of business, networking, and education. Produced by the Specialty Coffee Association (SCA), the trade show and conference are proudly supported by Host Sponsor BTW Water + More; Platinum Sponsor Barista Attitude; Diamond Sponsor Nestlé Professional; and Gold Sponsor Alpro. Café de Colombia will be featured as the Portrait Country with unique cultural activations, and a pop-up café experience. "Geneva is the ideal location for hosting our flagship European tra

U.S.-Based Blockchain Kadena and Croatian Football Federation (HNS) Partner to Revolutionize Fan Engagement6.2.2025 09:00:00 CET | Press release

The Agreement Includes Regular Season Play as Well as the 2026 FIFA World Cup 2026 and UEFA EURO 2028 NEW YORK CITY, NEW YORK / ACCESS Newswire / February 6, 2025 / Kadena, the industry leader in scalable blockchain technology, and the Croatian Football Federation (HNS) have announced a groundbreaking partnership to provide a seamless digital fan engagement experience to Croatian national team fans. This partnership will encompass major global football events through 2028, including the 2026 FIFA World Cup and 2028 UEFA Euro Cup.Kadena and The Croatian Football Federation Enter Partnership to Revolutionize Fan Engagement This collaboration will introduce high-visibility activations, access to VIP experiences, and the migration of the HNS ERC-20 fan token, VATRENI, from Polygon to Kadena via the Kinesis Bridge. "The goal with the [VATRENI] token is to push the boundaries of traditional fan engagement opportunities of the past and introduce more of a future-focused fan experience. We're

Preservica Delivers Actionable Trusted Long-Term Data with New Innovations in AI and Active Digital Preservation6.2.2025 09:00:00 CET | Press release

BOSTON, MA AND OXFORD, UK / ACCESS Newswire / February 6, 2025 / Preservica, the industry leader in Active Digital Preservation™ archiving, today unveiled a series of groundbreaking innovations to its pioneering platform. These enhancements further simplify and automate the complex task of preserving critical long-term data, ensuring it remains instantly usable, reliable, and trusted for compliance and emerging AI use. With up to a third of digital content needing to be retained long-term (more than 7 years) according to IDC, unreadable or lost data from poor retention policies, obsolete file formats and accidental or intentional change or deletion is not only a serious compliance, reputational and legal risk but also impacts an organization's ability to leverage AI for value creation and process automation. "As digital content continues to rapidly grow in volume and complexity, having a robust and secure foundation of instantly useable, reliable and trusted long-term data has become a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye